Photo taken from Chordoma Foundation/X
Jul 13, 2024, 11:09
Promising results from a Phase 1 clinical trial – Chordoma Foundation
Chordoma Foundation made the following post on X:
“Promising results have emerged from a Phase 1 clinical trial testing a new drug from Erasca called ERAS-601 alone & in combo w/ cetuximab: Nearly all of the 13 chordoma patients enrolled had some tumor shrinkage. More.”
Source: Chordoma Foundation/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 26, 2024, 18:39
Oct 26, 2024, 18:30
Oct 26, 2024, 18:28
Oct 26, 2024, 18:16
Oct 26, 2024, 18:03